Biotech · Private company
Vitti Labs, LLC
Track this companyFree. Adds Vitti Labs, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- VL-PX10 and VL-P22 plus standard carePhase 2 · Pulmonary FibrosisClinicalTrials.gov · fetched Nov 12, 2026
- EV-Pure™ and WJ-Pure™Phase 1 · COVID-19 Acute Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- VL-PX10Phase 1 · Premature Ovarian InsufficiencyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)PHASE1 · SUSPENDED · started Mar 20, 2025ClinicalTrials.gov NCT05387278 · fetched Nov 12, 2026
- A Proof of Concept Study to Evaluate Exosomes From Human Mesenchymal Stem Cells in Women With Premature Ovarian Insufficiency (POI)PHASE1 · SUSPENDED · started Oct 6, 2023ClinicalTrials.gov NCT06072794 · fetched Nov 12, 2026
- Safety and Effectiveness of VL-PX10 + VL-P22 Treatment on Pulmonary Fibrosis Secondary to Covid-19PHASE2 · SUSPENDED · started Nov 30, 2022ClinicalTrials.gov NCT05387239 · fetched Nov 12, 2026